| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $214.7M | +27.9% |
| SG&A Expense | $70.9M | +44.6% |
| Operating Income | -$285.6M | -31.7% |
| Pre-tax Income | -$255.6M | -40.3% |
| Income Tax | $278K | +1444.4% |
| Net Income | -$255.8M | -40.5% |
| EPS (Basic) | -$4.22 | -27.9% |
| EPS (Diluted) | -$4.22 | -27.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $131.5M | -7.2% |
| Short-term Investments | $598.6M | +58.0% |
| Current Assets | $741.4M | +40.0% |
| Total Assets | $937.1M | +24.3% |
| Current Liabilities | $27.9M | -2.3% |
| Total Liabilities | $33.3M | -10.5% |
| Stockholders' Equity | $903.9M | +26.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$227.4M | -32.9% |
| Capital Expenditures | $5.1M | +346.8% |
| Investing Cash Flow | -$179.6M | +40.2% |
| Financing Cash Flow | $396.5M | -19.9% |
| Free Cash Flow | -$232.6M | -35.0% |